Variant report

Variant	nsv982128
Chromosome Location	chr8:94966644-94973304
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr8:94966714-94967166	GM12878	blood:	n/a	n/a
2	BACH1	chr8:94970213-94970324	H1-hESC	embryonic stem cell:	n/a	n/a
3	BATF	chr8:94966773-94967126	GM12878	blood:	n/a	n/a
4	BATF	chr8:94966750-94967131	GM12878	blood:	n/a	n/a
5	BCL11A	chr8:94966832-94967062	GM12878	blood:	n/a	n/a
6	BCL11A	chr8:94966780-94967112	GM12878	blood:	n/a	n/a
7	BCL3	chr8:94966805-94967110	GM12878	blood:	n/a	n/a
8	BHLHE40	chr8:94967809-94968017	HepG2	liver:	n/a	n/a
9	BHLHE40	chr8:94973231-94973494	GM12878	blood:	n/a	n/a
10	BHLHE40	chr8:94967689-94967889	K562	blood:	n/a	n/a
11	BRCA1	chr8:94973174-94973548	Hela-S3	cervix:	n/a	n/a
12	CEBPB	chr8:94970006-94970240	A549	lung:	n/a	chr8:94970130-94970143 chr8:94970130-94970141 chr8:94970130-94970143 chr8:94970132-94970141 chr8:94970132-94970143
13	CEBPB	chr8:94969873-94970337	MCF-7	breast:	n/a	chr8:94970130-94970143 chr8:94970130-94970141 chr8:94970130-94970143 chr8:94970132-94970141 chr8:94970132-94970143
14	CEBPB	chr8:94969989-94970291	K562	blood:	n/a	chr8:94970130-94970143 chr8:94970130-94970141 chr8:94970130-94970143 chr8:94970132-94970141 chr8:94970132-94970143
15	CEBPB	chr8:94969989-94970297	HepG2	liver:	n/a	chr8:94970130-94970143 chr8:94970130-94970141 chr8:94970130-94970143 chr8:94970132-94970141 chr8:94970132-94970143
16	CEBPB	chr8:94969881-94970392	MCF-7	breast:	n/a	chr8:94970130-94970143 chr8:94970130-94970141 chr8:94970130-94970143 chr8:94970132-94970141 chr8:94970132-94970143
17	CTCF	chr8:94973262-94973488	GM10266	blood:	n/a	n/a
18	CTCF	chr8:94973300-94973450	SAEC	small airway:	n/a	n/a
19	CTCF	chr8:94973300-94973450	WERI-Rb-1	eye:	n/a	n/a
20	CTCF	chr8:94971720-94971870	HMF	breast:	n/a	n/a
21	CTCF	chr8:94971660-94971810	AG04449	skin:	n/a	n/a
22	CTCF	chr8:94971050-94971096	GM10266	blood:	n/a	n/a
23	CTCF	chr8:94971620-94971770	HUVEC	blood vessel:	n/a	n/a
24	CTCF	chr8:94973300-94973450	HPF	lung:	n/a	n/a
25	CTCF	chr8:94973236-94973473	Kidney_OC	kidney:	n/a	n/a
26	CTCF	chr8:94973300-94973450	GM12870	blood:	n/a	n/a
27	CTCF	chr8:94973300-94973450	HMEC	breast:	n/a	n/a
28	CTCF	chr8:94971700-94971850	AG09309	skin:	n/a	n/a
29	CTCF	chr8:94973219-94973496	A549	lung:	n/a	n/a
30	CTCF	chr8:94973300-94973450	AG10803	skin:	n/a	n/a
31	CTCF	chr8:94973280-94973430	HepG2	liver:	n/a	n/a
32	CTCF	chr8:94973200-94973350	Hela-S3	cervix:	n/a	n/a
33	CTCF	chr8:94973098-94973607	A549	lung:	n/a	n/a
34	CTCF	chr8:94971720-94971870	AG10803	skin:	n/a	n/a
35	CTCF	chr8:94973240-94973390	HRPEpiC	eye:	n/a	n/a
36	CTCF	chr8:94973196-94973488	K562	blood:	n/a	n/a
37	CTCF	chr8:94973245-94973468	GM19240	blood:	n/a	n/a
38	CTCF	chr8:94973249-94973507	SK-N-SH_RA	brain:	n/a	n/a
39	CTCF	chr8:94973253-94973480	K562	blood:	n/a	n/a
40	CTCF	chr8:94973114-94973517	ECC-1	luminal epithelium:	n/a	n/a
41	CTCF	chr8:94973300-94973450	SK-N-SH_RA	brain:	n/a	n/a
42	CTCF	chr8:94973280-94973430	GM06990	blood:	n/a	n/a
43	CTCF	chr8:94971620-94971770	AoAF	blood vessel:	n/a	n/a
44	CTCF	chr8:94973280-94973430	AG09309	skin:	n/a	n/a
45	CTCF	chr8:94973300-94973450	GM06990	blood:	n/a	n/a
46	CTCF	chr8:94973300-94973450	HepG2	liver:	n/a	n/a
47	CTCF	chr8:94967740-94967890	HUVEC	blood vessel:	n/a	n/a
48	CTCF	chr8:94973271-94973405	H1-hESC	embryonic stem cell:	n/a	n/a
49	CTCF	chr8:94971680-94971830	HMF	breast:	n/a	n/a
50	CTCF	chr8:94971520-94971670	AG04450	lung:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr8:94836556..94838849-chr8:94970213..94972114,2	MCF-7	breast:
2	chr8:94834374..94834944-chr8:94970861..94971627,2	MCF-7	breast:
3	chr8:94577712..94578279-chr8:94972934..94973446,2	MCF-7	breast:
4	chr8:94832955..94835599-chr8:94972783..94974744,2	MCF-7	breast:
5	chr8:94834077..94835230-chr8:94972631..94974077,23	MCF-7	breast:
6	chr8:94834218..94834817-chr8:94972873..94973772,4	K562	blood:
7	chr8:94927400..94930777-chr8:94970323..94974580,5	MCF-7	breast:
8	chr8:94706075..94706748-chr8:94973244..94973871,2	K562	blood:
9	chr8:94927101..94932217-chr8:94967169..94973451,6	MCF-7	breast:
10	chr8:94705945..94706920-chr8:94972856..94973788,3	MCF-7	breast:
11	chr8:94965588..94968919-chr8:94970973..94974619,3	MCF-7	breast:
12	chr8:94965588..94968919-chr8:94970973..94974619,3	MCF-7	breast:
13	chr8:94936423..94938355-chr8:94966596..94969452,2	MCF-7	breast:
14	chr8:94967615..94969465-chr8:94986791..94988525,2	MCF-7	breast:
15	chr8:94833059..94835938-chr8:94971405..94974689,3	MCF-7	breast:
16	chr8:94834311..94835447-chr8:94972495..94973869,10	MCF-7	breast:
17	chr8:94705975..94707090-chr8:94972855..94974318,9	MCF-7	breast:

Variant related genes	Relation type
RPL34P18	TF binding region
ENSG00000164951	chromatin interactions
ENSG00000264448	chromatin interactions

Extended variants
information (count: 264 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:264 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs180682098	chr8:94966736-94966737	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs552209365	chr8:94966749-94966750	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs183798080	chr8:94966773-94966774	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs537182029	chr8:94966789-94966790	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs565729322	chr8:94966790-94966791	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs546472127	chr8:94966854-94966855	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs148179185	chr8:94966901-94966902	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs115418959	chr8:94966903-94966904	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs555619677	chr8:94966974-94966975	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs141072598	chr8:94966986-94966987	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs528240365	chr8:94967052-94967053	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs548076133	chr8:94967056-94967057	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs189419113	chr8:94967068-94967069	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs578254141	chr8:94967084-94967085	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs145251556	chr8:94967090-94967091	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs182065413	chr8:94967099-94967100	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs572924138	chr8:94967106-94967107	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs186001853	chr8:94967107-94967108	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs191702964	chr8:94967114-94967115	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs28649947	chr8:94967148-94967149	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs530598094	chr8:94967167-94967168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs544089148	chr8:94967172-94967173	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs564338554	chr8:94967196-94967197	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs3133999	chr8:94967203-94967204	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs536927081	chr8:94967230-94967231	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs367873097	chr8:94967243-94967244	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs546535456	chr8:94967305-94967306	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs566419022	chr8:94967324-94967325	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs62522989	chr8:94967338-94967339	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs370065888	chr8:94967367-94967368	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs542643177	chr8:94967374-94967375	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs549311386	chr8:94967393-94967394	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs569275251	chr8:94967427-94967428	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs557188431	chr8:94967434-94967435	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs557955882	chr8:94967461-94967462	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs181814449	chr8:94967477-94967478	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs114445936	chr8:94967499-94967500	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs561182055	chr8:94967555-94967556	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs374023213	chr8:94967563-94967564	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs145977228	chr8:94967572-94967573	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs138575580	chr8:94967575-94967576	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs149310544	chr8:94967582-94967583	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs3115938	chr8:94967615-94967616	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs186324536	chr8:94967633-94967634	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs377419876	chr8:94967658-94967659	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs570431127	chr8:94967690-94967691	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs3134000	chr8:94967717-94967718	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs191232764	chr8:94967736-94967737	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs532999932	chr8:94967737-94967738	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs552953501	chr8:94967792-94967793	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Ewing''s sarcoma	21437220	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Pancreatic cancer	21811587	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	17603634	CNVD
Testicular cancer	18059402	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
abnormal development	18461090	CNVD
Oral cancer	21386901	CNVD
Uveal melanoma	21693616	CNVD
Langer-Giedion syndrome	22283845	CNVD
Cancer	21637783	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	20632083	CNVD
Breast cancer	19602461	CNVD
Cancer	22429812	CNVD
Endometrial cancer	22040021	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	19627613	CNVD
Prostate cancer	21088497	CNVD
colon cancer	17210682	CNVD
Breast cancer	21264507	CNVD
Breast cancer	22028636	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	16751803	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Gastric cancer	17167181	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	16461572	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
head and neck squamous cell carcinoma	18028549	CNVD
Breast cancer	17001317	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Urothelial carcinoma	21177765	CNVD
Lung cancer	18438408	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Hepatocellular carcinoma	18803288	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	18628472	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	16573809	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Cancer	21949371	CNVD
Non-small cell lung cancer	21829676	CNVD
Multiple myeloma	16461302	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Acute myeloid leukemia	21358987	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Adenocarcinoma	21044232	CNVD
Squamous cell cancer	20885788	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	21399628	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
small cell lung cancer	20016488	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	17393978	CNVD
Burkitt''s lymphoma	18698080	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Bladder cancer	19088036	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17899364	CNVD
Acute myeloid leukemia	21251322	CNVD
Epilepsy	20502679	CNVD
Acute myeloid leukemia	19651601	CNVD
head and neck squamous cell carcinoma	19451471	CNVD
Renal cell carcinoma	18765545	CNVD
Basal cell lymphoma	17170743	CNVD
Mental retardation	17847001	CNVD
Neuropsychiatric disorder	20069037	CNVD
Colorectal cancer	16774939	CNVD
Autosomal-dominant progressive external ophthalmoplegia	19664747	CNVD
Colorectal cancer	21645411	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Breast cancer	21611746	CNVD

Chromatin state (count:156 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:94965400-94967400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
2	chr8:94965400-94967600	Weak transcription	HepG2	liver
3	chr8:94965400-94969800	Weak transcription	Fetal Lung	lung
4	chr8:94965600-94969000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
5	chr8:94965600-94971800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr8:94965800-94967200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
7	chr8:94965800-94967400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
8	chr8:94965800-94967400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
9	chr8:94965800-94967800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr8:94965800-94968600	Weak transcription	Fetal Intestine Large	intestine
11	chr8:94965800-94968600	Weak transcription	Fetal Intestine Small	intestine
12	chr8:94965800-94970200	Weak transcription	HUES6 Cell Line	embryonic stem cell
13	chr8:94966000-94969200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr8:94966200-94968400	Enhancers	Placenta	Placenta
15	chr8:94966400-94967400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
16	chr8:94967400-94967600	Enhancers	Left Ventricle	heart
17	chr8:94967400-94968000	Enhancers	ES-I3 Cell Line	embryonic stem cell
18	chr8:94967400-94968000	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr8:94967400-94968000	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
20	chr8:94967400-94968000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
21	chr8:94967400-94968000	Enhancers	Ovary	ovary
22	chr8:94967400-94968400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
23	chr8:94967400-94969200	Enhancers	HUVEC	blood vessel
24	chr8:94967400-94969400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr8:94967600-94969600	Enhancers	HepG2	liver
26	chr8:94967600-94970200	Weak transcription	Left Ventricle	heart
27	chr8:94967800-94968200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr8:94968000-94968200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
29	chr8:94968000-94968600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr8:94968000-94968800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
31	chr8:94968000-94973200	Weak transcription	Ovary	ovary
32	chr8:94968000-94973400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
33	chr8:94968200-94970200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr8:94968600-94970200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr8:94968600-94973400	Enhancers	Fetal Intestine Large	intestine
36	chr8:94968600-94973600	Enhancers	Fetal Intestine Small	intestine
37	chr8:94968800-94969200	Enhancers	Skeletal Muscle Female	skeletal muscle
38	chr8:94968800-94970800	Enhancers	ES-I3 Cell Line	embryonic stem cell
39	chr8:94969000-94969600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr8:94969200-94970200	Weak transcription	Skeletal Muscle Female	skeletal muscle
41	chr8:94969200-94970200	Weak transcription	HUVEC	blood vessel
42	chr8:94969400-94971400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr8:94969600-94970000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr8:94969600-94970400	Bivalent Enhancer	HepG2	liver
45	chr8:94969600-94970600	Enhancers	Pancreas	Pancrea
46	chr8:94969600-94970800	Enhancers	Liver	Liver
47	chr8:94969800-94970600	Enhancers	Fetal Lung	lung
48	chr8:94970000-94970400	Enhancers	Brain Cingulate Gyrus	brain
49	chr8:94970000-94970600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr8:94970000-94970600	Enhancers	Brain Anterior Caudate	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links